Spamdex - Spam Archive

Report spam

Send in your spam and get the offenders listed

Create a rule in outlook or simply forward the spam you receive to questions@spamdex.co.uk

Also in investis.com

Scapa Group Plc email alerting service

RNS Number : 2211B
Scapa Group PLC
08 January 2018
 

8 January 2018                                                                                                                  

Scapa Group plc

('Scapa' or 'the Company')

 

Directorate Changes

 

 

Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets, today announces the following directorate changes.

 

Mr Pierre Guyot will join the Board as an Independent Non-Executive Director with immediate effect, and will also become a member of the Board's Audit and Risk, Remuneration, and Nominations Committees upon his appointment.  Mr Guyot has over 30 years' experience in the international healthcare industry and is currently a Director of Permobil AB, Sweden, and s Surgical SA, France.  From January 2014 until 31 December 2017, Mr Guyot was a Director of Spineguard SA, France, and from 2007 to 2014, he was the Chief Executive Officer of Mölnlycke Health Care in Sweden. Prior to this, Mr Guyot served in various roles in sales and marketing and EMEA positions with Becton Dickinson, Johnson & Johnson, and Boston Scientific.

 

Mr Brendan McAtamney will join the Board as an Independent Non-Executive Director with effect from 1 February 2018, and will also become a member of the Board's Audit and Risk, Remuneration and Nominations Committees with effect from that date.  Mr McAtamney was appointed Chief Executive Officer of UDG Healthcare on 2 February 2016, having served as an executive director since December 2013, and having originally joined UDG as Chief Operating Officer in 2013.  Prior to that, Mr McAtamney has held various senior management positions with Abbott, latterly as Vice President Commercial and Corporate Officer within its Established Pharmaceuticals Division.

 

Mr Richard Perry, Senior Independent Non-Executive Director, who having served on the Board since 2005, has indicated that he does not intend to offer himself for re-election at the 2018 AGM.

 

Larry Pentz, Scapa Group Chairman, commented: "We are pleased to welcome Pierre and Brendan to the Board and look forward to leveraging the wealth of knowledge and experience they each bring to their roles.  Although Richard Perry will continue in his role as the Senior Independent Director up until his retirement in July 2018, I would also like to take this opportunity to thank Richard for the advice and support he has given me as Chairman and for his contribution and commitment to the Company and the Board of Directors over the last twelve years."

 

Composition of Board Committees

The following table sets out the composition, following the implementation of the above appointments, of the Board Committees:-

Committee

Chairman

Members

Nominations

Lawrence Pentz

David Blackwood

Martin Sawkins

Richard Perry

Pierre Guyot1

Brendan McAtamney2

 

Remuneration

Martin Sawkins

David Blackwood

Richard Perry

Lawrence Pentz

Pierre Guyot1

Brendan McAtamney2

 

Audit and Risk

David Blackwood

Martin Sawkins

Richard Perry

Lawrence Pentz

Pierre Guyot1

Brendan McAtamney2

 

 

1 With effect from 8 January 2018

2 With effect from 1 February 2018

 

The Company makes the following disclosures in relation to Mr Guyot's appointment in accordance with Rule 17 of and paragraph (g) of Schedule Two of the AIM Rules for Companies:

 

1.            Director's full name: Pierre Roger Michel Guyot

Director's age: 53 years

 

2.            Other directorships / partnerships held during the last five years, including appointment and, where appropriate, resignation dates:

 

Name of Company / Partnership

Date appointed

Date resigned

 

 

 

SC Garonne

25 February 2015

na

BSN Medical

1 August 2015

3 April 2017

Spineguard SA

15 January 2014

31 December 2017

s Surgical SA

1 January 2014

na

Permobil AB

3 May 2013

na

Mölnlycke Health Care Ltd

10 July 2007

31 March 2014

MHC UK Ltd

9 July 2007

31 March 2014

SSR Seven Ltd

15 May 2007

na

 

 

 

3.            Shareholding: Mr Guyot does not hold any shares in the Company.

 

4.            Other information: There is no other information required to be disclosed in relation to Mr Guyot under paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

The Company makes the following disclosures in relation to Mr McAtamney's appointment in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies:

 

1.            Director's full name: Brendan Patrick McAtamney

Director's age: 55 years

 

2.            Other directorships / partnerships held during the last five years, including appointment and, where appropriate, resignation dates:

 

Name of Company/Partnership

Date appointed

Date resigned

 

UDG Healthcare plc

16 December 2013

na

 

Aquilant Analytical Sciences Ltd 

16 December 2013

na

 

Aquilant Medical (ROI) Ltd

16 December 2013

na

 

Aquilant Scientific (ROI) Ltd

16 December 2013

na

 

UDG Healthcare Ireland Ltd

16 December 2013

na

 

UDG Healthcare Ayrtons (Dublin) Ltd

16 December 2013

na

 

Aquilant Ltd

30 October 2013

na

 

Aquilant Scientific (UK) Ltd

30 October 2013

na

 

Ashfield Healthcare Ltd

3 February 2016

na

 

Unitech Equipment Ltd

30 October 2013

na

 

UDG Healthcare (UK) Holdings Ltd

1 June 2015

na

 

Abbott Laboratories GmbH

31 May 2010

31 July 2013

 

Abbott Products GmbH

31 May 2010

31 July 2013

 

Abbott Laboratories

28 February 2010

31 July 2013

 

Abbott Laboratories Inc

28 February 2010

31 July 2013

 

Laboratoires Fournier S.A.S

31 May 2010

8 January 2013

 

Abbott Truecare Pharma Private Ltd

31 May 2010

31 July 2013

 

 

 

 

 

3.            Shareholding: Mr McAtamney does not hold any shares in the Company.

 

4.            Other information: There is no other information required to be disclosed in relation to Mr McAtamney under paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

 

For further information:

 

Scapa Group plc:

Wendy Baker                                                                                              +44 (0) 161 301 7400

Group General Counsel and Company Secretary

 

Numis Securities Limited:                                                                     +44 (0) 20 7260 1000

Mark Lander

Richard Thomas (Nominated Adviser)


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASSAFSAFASESF


To unsubscribe or to change your subscriber options, go to:

http://www.scapa.com/en/EMailAlerts

---------------------------

All titles, content, publisher names, trademarks, artwork, and associated imagery are trademarks and/or copyright material of their respective owners. All rights reserved. The Spam Archive website contains material for general information purposes only. It has been written for the purpose of providing information and historical reference containing in the main instances of business or commercial spam.

Many of the messages in Spamdex's archive contain forged headers in one form or another. The fact that an email claims to have come from one email address or another does not mean it actually originated at that address! Please use spamdex responsibly.


Yes YOU! Get INVOLVED - Send in your spam and report offenders

Create a rule in outlook or simply forward the junk email you receive to questions@spamdex.co.uk | See contributors

Google + Spam 2010- 2017 Spamdex - The Spam Archive for the internet. unsolicited electric messages (spam) archived for posterity. Link to us and help promote Spamdex as a means of forcing Spammers to re-think the amount of spam they send us.

The Spam Archive - Chronicling spam emails into readable web records index for all time

Please contact us with any comments or questions at questions@spamdex.co.uk. Spam Archive is a non-profit library of thousands of spam email messages sent to a single email address. A number of far-sighted people have been saving all their spam and have put it online. This is a valuable resource for anyone writing Bayesian filters. The Spam Archive is building a digital library of Internet spam. Your use of the Archive is subject to the Archive's Terms of Use. All emails viewed are copyright of the respected companies or corporations. Thanks to Benedict Sykes for assisting with tech problems and Google Indexing, ta Ben.

Our inspiration is the "Internet Archive" USA. "Libraries exist to preserve society's cultural artefacts and to provide access to them. If libraries are to continue to foster education and scholarship in this era of digital technology, it's essential for them to extend those functions into the digital world." This is our library of unsolicited emails from around the world. See https://archive.org. Spamdex is in no way associated though. Supporters and members of http://spam.abuse.net Helping rid the internet of spam, one email at a time. Working with Inernet Aware to improve user knowlegde on keeping safe online. Many thanks to all our supporters including Vanilla Circus for providing SEO advice and other content syndication help | Link to us | Terms | Privacy | Cookies | Complaints | Copyright | Spam emails / ICO | Spam images | Sitemap | All hosting and cloud migration by Cloudworks.

Important: Users take note, this is Spamdex - The Spam Archive for the internet. Some of the pages indexed could contain offensive language or contain fraudulent offers. If an offer looks too good to be true it probably is! Please tread, carefully, all of the links should be fine. Clicking I agree means you agree to our terms and conditions. We cannot be held responsible etc etc.

The Spam Archive - Chronicling spam emails into readable web records

The Glass House | London | SW19 8AE |
Spamdex is a digital archive of unsolicited electronic mail 4.9 out of 5 based on reviews
Spamdex - The Spam Archive Located in London, SW19 8AE. Phone: 08000 0514541.